BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23839295)

  • 1. Cellular expression and biological activities of alternatively spliced forms of tissue factor pathway inhibitor.
    Maroney SA; Hansen KG; Mast AE
    Curr Opin Hematol; 2013 Sep; 20(5):403-9. PubMed ID: 23839295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biology of tissue factor pathway inhibitor.
    Wood JP; Ellery PE; Maroney SA; Mast AE
    Blood; 2014 May; 123(19):2934-43. PubMed ID: 24620349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the inhibitory activities of human tissue factor pathway inhibitor (TFPI)α and TFPIβ.
    Maroney SA; Ellery PE; Wood JP; Ferrel JP; Martinez ND; Mast AE
    J Thromb Haemost; 2013 May; 11(5):911-8. PubMed ID: 23480518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TFPIα and TFPIβ are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity.
    Stavik B; Tinholt M; Sletten M; Skretting G; Sandset PM; Iversen N
    J Hematol Oncol; 2013 Jan; 6():5. PubMed ID: 23320987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue factor pathway inhibitor-alpha inhibits prothrombinase during the initiation of blood coagulation.
    Wood JP; Bunce MW; Maroney SA; Tracy PB; Camire RM; Mast AE
    Proc Natl Acad Sci U S A; 2013 Oct; 110(44):17838-43. PubMed ID: 24127605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New insights into the biology of tissue factor pathway inhibitor.
    Maroney SA; Mast AE
    J Thromb Haemost; 2015 Jun; 13 Suppl 1(0 1):S200-7. PubMed ID: 26149025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein S is a cofactor for platelet and endothelial tissue factor pathway inhibitor-α but not for cell surface-associated tissue factor pathway inhibitor.
    Wood JP; Ellery PE; Maroney SA; Mast AE
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):169-76. PubMed ID: 24233490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of coagulation by tissue factor pathway inhibitor: Implications for hemophilia therapy.
    Mast AE; Ruf W
    J Thromb Haemost; 2022 Jun; 20(6):1290-1300. PubMed ID: 35279938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue Factor Pathway Inhibitor: Multiple Anticoagulant Activities for a Single Protein.
    Mast AE
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):9-14. PubMed ID: 26603155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternatively spliced isoforms of tissue factor pathway inhibitor.
    Maroney SA; Ellery PE; Mast AE
    Thromb Res; 2010 Apr; 125 Suppl 1():S52-6. PubMed ID: 20176395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cell-surface TFPIalpha and beta.
    Piro O; Broze GJ
    J Thromb Haemost; 2005 Dec; 3(12):2677-83. PubMed ID: 16246254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caveolae optimize tissue factor-Factor VIIa inhibitory activity of cell-surface-associated tissue factor pathway inhibitor.
    Maroney SA; Ellery PE; Wood JP; Ferrel JP; Bonesho CE; Mast AE
    Biochem J; 2012 Apr; 443(1):259-66. PubMed ID: 22239091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-evaluation of mouse tissue factor pathway inhibitor and comparison of mouse and human tissue factor pathway inhibitor physiology.
    Girard TJ; Grunz K; Lasky NM; Malone JP; Broze GJ
    J Thromb Haemost; 2018 Nov; 16(11):2246-2257. PubMed ID: 30194803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue factor-independent inhibition of thrombin generation by tissue factor pathway inhibitor-α.
    Thomassen MC; Heinzmann AC; Herfs L; Hartmann R; Dockal M; Scheiflinger F; Hackeng TM; Rosing J
    J Thromb Haemost; 2015 Jan; 13(1):92-100. PubMed ID: 25348176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue factor pathway inhibitor: structure-function.
    Broze GJ; Girard TJ
    Front Biosci (Landmark Ed); 2012 Jan; 17(1):262-80. PubMed ID: 22201743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine hematopoietic cell tissue factor pathway inhibitor limits thrombus growth.
    Maroney SA; Cooley BC; Ferrel JP; Bonesho CE; Mast AE
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):821-6. PubMed ID: 21233452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue factor pathway inhibitor-gamma is an active alternatively spliced form of tissue factor pathway inhibitor present in mice but not in humans.
    Maroney SA; Ferrel JP; Collins ML; Mast AE
    J Thromb Haemost; 2008 Aug; 6(8):1344-51. PubMed ID: 18503630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syndecan-3 and TFPI colocalize on the surface of endothelial-, smooth muscle-, and cancer cells.
    Tinholt M; Stavik B; Louch W; Carlson CR; Sletten M; Ruf W; Skretting G; Sandset PM; Iversen N
    PLoS One; 2015; 10(1):e0117404. PubMed ID: 25617766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet tissue factor pathway inhibitor modulates intravascular coagulation.
    Maroney SA; Mast AE
    Thromb Res; 2012 May; 129 Suppl 2(Suppl 2):S21-2. PubMed ID: 22425319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Translation of human tissue factor pathway inhibitor-β mRNA is controlled by alternative splicing within the 5' untranslated region.
    Ellery PE; Maroney SA; Martinez ND; Wickens MP; Mast AE
    Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):187-95. PubMed ID: 24233486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.